Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, Gjerdrum LM, Labuda T, Mathiesen AM, Grønbæk K, Wasik MA, Sokolowska-Wojdylo M, Queille-Roussel C, Gniadecki R, Ralfkiaer E, Geisler C, Litman T, Woetmann A, Glue C, Røpke MA, Skov L, Odum N.

Blood. 2011 Nov 24;118(22):5891-900. doi: 10.1182/blood-2011-06-358382. Epub 2011 Aug 24.

2.

MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.

Kitadate A, Ikeda S, Teshima K, Ito M, Toyota I, Hasunuma N, Takahashi N, Miyagaki T, Sugaya M, Tagawa H.

Oncogene. 2016 Jul 14;35(28):3692-704. doi: 10.1038/onc.2015.435. Epub 2015 Dec 7.

PMID:
26640145
3.

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.

Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, Marstrand T, Fredholm S, Iversen L, Wasik MA, Bonefeld CM, Geisler C, Krejsgaard T, Glue C, Røpke MA, Woetmann A, Skov L, Grønbæk K, Odum N.

Anticancer Res. 2014 Dec;34(12):7207-17. Erratum in: Anticancer Res. 2015 Feb;35(2):1219. Lindal, Lise [corrected to Lindahl, Lise M].

PMID:
25503151
4.

miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.

McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM.

J Invest Dermatol. 2014 Apr;134(4):1101-1107. doi: 10.1038/jid.2013.461. Epub 2013 Nov 7.

5.

MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.

Ito M, Teshima K, Ikeda S, Kitadate A, Watanabe A, Nara M, Yamashita J, Ohshima K, Sawada K, Tagawa H.

Blood. 2014 Mar 6;123(10):1499-511. doi: 10.1182/blood-2013-09-527739. Epub 2014 Jan 2.

6.

Early CTCL diagnosis, a (miR)age no more?

Mishra A, Porcu P.

Blood. 2011 Nov 24;118(22):5717-8. doi: 10.1182/blood-2011-09-379107. No abstract available.

7.

Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.

Kopp KL, Ralfkiaer U, Nielsen BS, Gniadecki R, Woetmann A, Ødum N, Ralfkiaer E.

APMIS. 2013 Nov;121(11):1020-4. doi: 10.1111/apm.12162. Epub 2013 Sep 6.

PMID:
24033365
8.
9.

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, Jønson L, Hagedorn PH, Krejsgaard T, Gniadecki R, Bonefeld CM, Skov L, Geisler C, Wasik MA, Ralfkiaer E, Ødum N, Woetmann A.

Cell Cycle. 2013 Jun 15;12(12):1939-47. doi: 10.4161/cc.24987. Epub 2013 May 15.

10.

Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.

Litvinov IV, Cordeiro B, Fredholm S, Ødum N, Zargham H, Huang Y, Zhou Y, Pehr K, Kupper TS, Woetmann A, Sasseville D.

Cell Cycle. 2014;13(18):2975-82. doi: 10.4161/15384101.2014.947759.

11.

A novel xenograft model of cutaneous T-cell lymphoma.

Krejsgaard T, Kopp K, Ralfkiaer E, Willumsgaard AE, Eriksen KW, Labuda T, Rasmussen S, Mathiesen AM, Geisler C, Lauenborg B, Becker JC, Zhang Q, Wasik MA, Odum N, Woetmann A.

Exp Dermatol. 2010 Dec;19(12):1096-102. doi: 10.1111/j.1600-0625.2010.01138.x.

PMID:
20629733
12.

Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.

Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E.

Dermatology. 2005;211(2):84-92.

PMID:
16088151
13.

Analysis of clonality in cutaneous T cell lymphoma and associated diseases.

Wood GS.

Ann N Y Acad Sci. 2001 Sep;941:26-30. Review.

PMID:
11594579
14.

miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma.

Manfè V, Biskup E, Rosbjerg A, Kamstrup M, Skov AG, Lerche CM, Lauenborg BT, Odum N, Gniadecki R.

PLoS One. 2012;7(1):e29541. doi: 10.1371/journal.pone.0029541. Epub 2012 Jan 3.

15.

The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).

Litvinov IV, Netchiporouk E, Cordeiro B, Doré MA, Moreau L, Pehr K, Gilbert M, Zhou Y, Sasseville D, Kupper TS.

Clin Cancer Res. 2015 Jun 15;21(12):2820-9. doi: 10.1158/1078-0432.CCR-14-3322. Epub 2015 Mar 16.

16.
17.

A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.

Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R.

J Virol. 2011 Oct;85(19):9877-86. doi: 10.1128/JVI.05558-11. Epub 2011 Aug 3.

18.

Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.

Hanafusa T, Matsui S, Murota H, Tani M, Igawa K, Katayama I.

Clin Exp Immunol. 2013 Jun;172(3):507-12. doi: 10.1111/cei.12073.

19.

The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.

Li Y, Vecchiarelli-Federico LM, Li YJ, Egan SE, Spaner D, Hough MR, Ben-David Y.

Blood. 2012 May 10;119(19):4486-98. doi: 10.1182/blood-2011-09-378687. Epub 2012 Mar 26.

20.

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.

Delfau-Larue MH, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M, Bagot M, Farcet JP.

Blood. 2000 Nov 1;96(9):2987-92.

Supplemental Content

Support Center